We know the genes, but not their functions—to resolve this long-standing bottleneck in microbial research, a joint research ...

On Thursday, Deepwater Asset Management's managing partner Gene Munster said new signals from Nvidia Corp (NASDAQ:NVDA) and ...

Sometimes, in genetics, two wrongs do make a right. A research team has recently shown that two harmful genetic variants, ...

Cell and gene therapies present promising opportunities, especially in oncology, blood disorders, and neurology. Investors prioritize scalable platforms and clear regulatory paths. Focus has shifted ...

During his remarks at the White House in December, President Trump insulted reporters' intelligence. Trump stated, "The people from the fake news would not do well." ...

We know the genes, but not their functions.” To resolve this long-standing bottleneck in microbial research, a joint research ...

Picture CRISPR-Cas9, a gene editing technology, as a GPS-guided scalpel: gRNA directs the Cas9 enzyme, a protein that cuts ...

A preclinical study uncovered a new gene therapy that targets pain centers in the brain while eliminating the risk of ...

Generative Bionics, an Italian company developing Physical AI powered humanoid robots, unveiled its first concept at CES 2026 ...

During a House Ways and Means Committee hearing last year in June, Treasury Secretary Scott Bessent earned himself a scolding ...

The cell and gene therapy market is at a pivotal point, with a surge in approvals and a maturing pipeline. While oncology ...

Traditionally, cancer diagnosis and prognosis rely heavily on histopathological examination, where tissue morphology is evaluated under the microscope. However, the molecular ...